Jen Robinson | Vice President, Investor Relations |
Steven Hoerter | President and Chief Executive Officer |
Daniel Martin | Chief Commercial Officer |
Matthew Sherman | Chief Medical Officer |
Tucker Kelly | Executive Vice President and Chief Financial Officer |
Jessica Fye | JPMorgan |
Allison Bratzel | Piper Sandler |
Michael Schmidt | Guggenheim |
Eun Yang | Jefferies |
Andrew Berens | SVB Leerink |
Peter Lawson | Barclays |
Reni Benjamin | JMP Securities |
Robyn Karnauskas | Truist |
Good afternoon, everyone, and welcome to the Deciphera Pharmaceuticals Fourth Quarter and Full Year 2020 Financial Results Conference Call. Today's call is being recorded. At this time, I would now like to turn the call over to Jen Robinson, Vice President, Investor Relations. Jen?
Welcome and thank you for joining us today to discuss the Deciphera's fourth quarter and full year 2020 financial results.